POMC, proopiomelanocortin, 5443

N. diseases: 873; N. variants: 39
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0038587
Disease: Substance Withdrawal Syndrome
Substance Withdrawal Syndrome
0.310 Biomarker disease BEFREE The current study examined whether exogenous β-EP, delivered using an adenoviral vector into the CNS could attenuate morphine withdrawal syndrome in rats. 21983207 2011
CUI: C0038587
Disease: Substance Withdrawal Syndrome
Substance Withdrawal Syndrome
0.310 Therapeutic disease CTD_human Circadian alteration in neurobiology during protracted opiate withdrawal in rats. 20738730 2010
CUI: C0038587
Disease: Substance Withdrawal Syndrome
Substance Withdrawal Syndrome
0.310 Biomarker disease CTD_human Circadian alteration in neurobiology during protracted opiate withdrawal in rats. 20738730 2010
CUI: C0038587
Disease: Substance Withdrawal Syndrome
Substance Withdrawal Syndrome
0.310 Biomarker disease CTD_human Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. 15689546 2005
CUI: C0038587
Disease: Substance Withdrawal Syndrome
Substance Withdrawal Syndrome
0.310 Biomarker disease CTD_human Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids. 15714323 2005
CUI: C0038587
Disease: Substance Withdrawal Syndrome
Substance Withdrawal Syndrome
0.310 Therapeutic disease CTD_human Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. 15689546 2005
CUI: C0038587
Disease: Substance Withdrawal Syndrome
Substance Withdrawal Syndrome
0.310 Therapeutic disease CTD_human Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids. 15714323 2005
CUI: C0038587
Disease: Substance Withdrawal Syndrome
Substance Withdrawal Syndrome
0.310 Therapeutic disease CTD_human Changes in adrenocorticotropic hormone (ACTH) and cortisol levels in drug addicts treated by a new and rapid detoxification procedure using acupuncture and naloxone. 225122 1979
CUI: C0038587
Disease: Substance Withdrawal Syndrome
Substance Withdrawal Syndrome
0.310 Biomarker disease CTD_human Changes in adrenocorticotropic hormone (ACTH) and cortisol levels in drug addicts treated by a new and rapid detoxification procedure using acupuncture and naloxone. 225122 1979